1,307 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Article Searches
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2233406/mirum-pharmaceuticals-inc-mirm-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2233406 Feb 28, 2024 - Mirum Pharmaceuticals, Inc. (MIRM) delivered earnings and revenue surprises of -94.12% and 4.23%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Castle Biosciences, Inc. (CSTL) Reports Q4 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2233438/castle-biosciences-inc-cstl-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2233438 Feb 28, 2024 - Castle Biosciences, Inc. (CSTL) delivered earnings and revenue surprises of 88.10% and 28.85%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
24 Top Stocks to Buy Now in March 2024 https://www.fool.com/investing/2024/02/28/24-top-stocks-to-buy-now-in-march-2024/?source=iedfolrf0000001 Feb 28, 2024 - This list of specular stocks includes growth stocks, dividend stocks, and, perhaps best of all, artificial intelligence stocks.
Are You Looking for a Top Momentum Pick? Why Spotify (SPOT) is a Great Choice https://www.zacks.com/stock/news/2234078/are-you-looking-for-a-top-momentum-pick-why-spotify-spot-is-a-great-choice?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2234078 Feb 29, 2024 - Does Spotify (SPOT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Quanterix Corporation (QTRX) Reports Q4 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2234181/quanterix-corporation-qtrx-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2234181 Feb 29, 2024 - Quanterix Corporation (QTRX) delivered earnings and revenue surprises of -17.86% and 13.02%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Why Prestige Consumer Healthcare (PBH) is a Top Momentum Stock for the Long-Term https://www.zacks.com/stock/news/2233924/why-prestige-consumer-healthcare-pbh-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2233924 Feb 29, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Navitas Semiconductor Corporation (NVTS) Reports Q4 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2234191/navitas-semiconductor-corporation-nvts-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2234191 Feb 29, 2024 - Navitas Semiconductor Corporation (NVTS) delivered earnings and revenue surprises of 20% and 1.46%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Top Stock Reports for Costco, Walt Disney & AstraZeneca https://www.zacks.com/commentary/2233623/top-stock-reports-for-costco-walt-disney-astrazeneca?cid=CS-ZC-FT-research_daily-2233623 Feb 29, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Costco Wholesale Corporation (COST), The Walt Disney Company (DIS) and AstraZeneca PLC (AZN).
Why Jacobs Solutions (J) is a Top Growth Stock for the Long-Term https://www.zacks.com/stock/news/2233910/why-jacobs-solutions-j-is-a-top-growth-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2233910 Feb 29, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Pactiv Evergreen Inc. (PTVE) Tops Q4 Earnings Estimates https://www.zacks.com/stock/news/2234218/pactiv-evergreen-inc-ptve-tops-q4-earnings-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2234218 Feb 29, 2024 - Pactiv Evergreen Inc. (PTVE) delivered earnings and revenue surprises of 135.71% and 0.80%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Pages: 1...56789101112131415...131

<<<Page 10>